ChronoScale Corporation Common Stock (NASDAQ:CHRN) Stock Price Down 16.1% – Here’s What Happened

Shares of ChronoScale Corporation Common Stock (NASDAQ:CHRN) fell 16.1% during mid-day trading on Wednesday. The stock traded as low as $11.41 and last traded at $11.48. Approximately 145,743 shares traded hands during mid-day trading, a decline of 34% from the average daily volume of 221,623 shares. The stock had previously closed at $13.68.

Analyst Ratings Changes

Several analysts recently commented on CHRN shares. Weiss Ratings downgraded ChronoScale Corporation Common Stock from a “sell (d)” rating to a “sell (d-)” rating in a research note on Friday, October 23rd. Northland Securities started coverage on ChronoScale Corporation Common Stock in a research note on Friday, September 18th. They issued an “outperform” rating and a $32.00 target price for the company. Finally, Compass Point initiated coverage on ChronoScale Corporation Common Stock in a report on Friday, October 16th. They issued a “buy” rating and a $25.00 price target for the company. Two analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $21.00.

ChronoScale Corporation Common Stock Stock Down 14.3%

The company has a current ratio of 0.30, a quick ratio of 0.30 and a debt-to-equity ratio of 0.02. The firm’s 50 day moving average price is $18.22 and its two-hundred day moving average price is $16.02. The company has a market capitalization of $1.71 billion, a P/E ratio of -2.72 and a beta of 1.12.

ChronoScale Corporation Common Stock (NASDAQ:CHRN) last issued its quarterly earnings results on Wednesday, October 14th. The company reported ($0.29) EPS for the quarter. The business had revenue of $41.48 million for the quarter. ChronoScale Corporation Common Stock had a negative return on equity of 66.16% and a negative net margin of 135.66%. Equities research analysts forecast that ChronoScale Corporation Common Stock will post -0.49 EPS for the current year.

ChronoScale Corporation Common Stock Company Profile

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods.